Mid West One Financial Group, Inc. Biomarin Pharmaceutical Inc Transaction History

Mid West One Financial Group, Inc.

  • $549 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $383,420 - $438,290
-5,128 Closed
0 $0
Q2 2021

Aug 17, 2021
SELL
$75.51 - $84.79 $8,910 - $10,005
-118 Reduced 2.25%
5,128 $428,000
Q1 2021

May 18, 2021
BUY
$74.73 - $90.69 $392,033 - $475,759
5,246 New
5,246 $396,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mid West One Financial Group, Inc. Portfolio

Follow Mid West One Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid West One Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email